Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
- Status
- COMPLETED
- Phase
- PHASE3
Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants
- Status
- COMPLETED
- Phase
- PHASE3
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects
- Status
- TERMINATED
- Phase
- PHASE3
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
- Status
- COMPLETED
- Phase
- PHASE3
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response
- Status
- COMPLETED
- Phase
- PHASE4
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects
- Status
- TERMINATED
- Phase
- PHASE3
Study In Patients With Insulin Resistance
- Status
- COMPLETED
- Phase
- PHASE3
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
- Status
- COMPLETED
- Phase
- PHASE3
Treatment Of Symptomatic Asthma In Children
- Status
- COMPLETED
- Phase
- PHASE4
In-Patient Study In Schizophrenic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.
- Status
- COMPLETED
- Phase
- PHASE2
Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region
- Status
- COMPLETED
- Phase
- PHASE2